We evaluated the acute and two-year safety and efficacy of using the CoreValve, Evolut R, and Evolut PRO valves for treating failed surgical bioprosthesis from the Italian CoreValve Clinical Service Project.
We evaluated the acute and two-year safety and efficacy of using the CoreValve, Evolut R, and Evolut PRO valves for treating failed surgical bioprosthesis from the Italian CoreValve Clinical Service Project.
The use of Impella ventricular support systems and intra-aortic balloon pump (IABP) in acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) has increased in recent years and expanded treatment options, although the...
The use of Impella ventricular support systems and intra-aortic balloon pump (IABP) in acute myocardial infarction (AMI) complicated by cardiogenic shock (CS) has increased in recent years and expanded treatment options, although the...
Percutaneous left atrial appendage occlusion (LAAO) with the Watchman device is FDA approved for stroke prevention in patients with nonvalvular atrial fibrillation who have an appropriate indication.
Percutaneous left atrial appendage occlusion (LAAO) with the Watchman device is FDA approved for stroke prevention in patients with nonvalvular atrial fibrillation who have an appropriate indication.
Infrapopliteal arterial disease results from 2 major etiologies: medial calcification and intimal atheromatous plaque. Lesion calcification constitutes one of the most widely encountered risk factors for percutaneous transluminal angioplasty...
Infrapopliteal arterial disease results from 2 major etiologies: medial calcification and intimal atheromatous plaque. Lesion calcification constitutes one of the most widely encountered risk factors for percutaneous transluminal angioplasty...
The study aims to assess real-life short- and long-term outcomes of patients undergoing primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) complicated with cardiogenic shock (CS). Outcome...
The study aims to assess real-life short- and long-term outcomes of patients undergoing primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) complicated with cardiogenic shock (CS). Outcome...
A 70-year-old female was taken up for optical coherence tomography (OCT)-guided percutaneous coronary intervention (PCI) of a calcified left anterior descending artery (LAD).
A 70-year-old female was taken up for optical coherence tomography (OCT)-guided percutaneous coronary intervention (PCI) of a calcified left anterior descending artery (LAD).
The current guidelines recommend at least 6 months of antithrombotic and antibiotic prophylaxis following atrial septal occluding device placement using the phrase “until endothelialization.”
The current guidelines recommend at least 6 months of antithrombotic and antibiotic prophylaxis following atrial septal occluding device placement using the phrase “until endothelialization.”
A 58-year-old man presented to the emergency room with squeezing chest pain and palpitations. Electrocardiography (ECG) showed wide QRS tachycardia with a heart rate of 210 bpm and an absence of P waves.
A 58-year-old man presented to the emergency room with squeezing chest pain and palpitations. Electrocardiography (ECG) showed wide QRS tachycardia with a heart rate of 210 bpm and an absence of P waves.
"Instead of relying on dedicated CT scans of coronary arteries, which are rare and not always covered by insurance, to find heart disease, we seek to use AI to help screen abdominal CT scans that are done for many reasons," said study senior...
"Instead of relying on dedicated CT scans of coronary arteries, which are rare and not always covered by insurance, to find heart disease, we seek to use AI to help screen abdominal CT scans that are done for many reasons," said study senior...
"In our current study, at week 4 after ischemia/reperfusion, we observed a significant 35.8 percent decrease in the infarct area in the hearts treated with the KO/OEhiPSC-cardiomyocyte spheroids," said Jianyi "Jay" Zhang, MD, PhD.
"In our current study, at week 4 after ischemia/reperfusion, we observed a significant 35.8 percent decrease in the infarct area in the hearts treated with the KO/OEhiPSC-cardiomyocyte spheroids," said Jianyi "Jay" Zhang, MD, PhD.
The study, published in the Journal of the American College of Cardiology (JACC), looked at detailed heart imaging data from 3,635 people who lived close to four major airports in England.
The study, published in the Journal of the American College of Cardiology (JACC), looked at detailed heart imaging data from 3,635 people who lived close to four major airports in England.
Women may be missing a diagnosis of a potentially deadly heart condition due to guidelines that don't account for natural differences in sex and body size, according to a new study led by UCL (University College London) researchers and funded...
Women may be missing a diagnosis of a potentially deadly heart condition due to guidelines that don't account for natural differences in sex and body size, according to a new study led by UCL (University College London) researchers and funded...
In a national study of over 40,000 people with Medicare and commercial insurance, 81.6% of patients did not have to pay for their initial cardiac rehabilitation session. The medically supervised program lasts up to 36 sessions.
In a national study of over 40,000 people with Medicare and commercial insurance, 81.6% of patients did not have to pay for their initial cardiac rehabilitation session. The medically supervised program lasts up to 36 sessions.
Boston Scientific News
Boston Scientific Corporation announced data supporting the use of the WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device during a late-breaking science session at AF Symposium 2025.
A prespecified...
Boston Scientific News
Boston Scientific Corporation announced data supporting the use of the WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device during a late-breaking science session at AF Symposium 2025.
A prespecified...
The Symplicity Spyral RDN system, approved by the U.S. FDA in November 2023, is an innovative, minimally invasive procedure that delivers radiofrequency energy to nerves near the kidneys that can become overactive and contribute to high blood...
The Symplicity Spyral RDN system, approved by the U.S. FDA in November 2023, is an innovative, minimally invasive procedure that delivers radiofrequency energy to nerves near the kidneys that can become overactive and contribute to high blood...
This agreement includes Contego Medical’s portfolio of commercially available products, including the recently FDA approved Neuroguard IEP® System, a unique 3-in-1 carotid stenting system that combines a high-performance stent, post-dilation...
This agreement includes Contego Medical’s portfolio of commercially available products, including the recently FDA approved Neuroguard IEP® System, a unique 3-in-1 carotid stenting system that combines a high-performance stent, post-dilation...
FastWave's commitment to providing physicians with highly deliverable IVL catheters that offer durable, 360-degree sonic output has led to the rapid development of a pipeline of IVL systems that hold the potential to positively impact patient...
FastWave's commitment to providing physicians with highly deliverable IVL catheters that offer durable, 360-degree sonic output has led to the rapid development of a pipeline of IVL systems that hold the potential to positively impact patient...
"Instead of relying on dedicated CT scans of coronary arteries, which are rare and not always covered by insurance, to find heart disease, we seek to use AI to help screen abdominal CT scans that are done for many reasons," said study senior...
"Instead of relying on dedicated CT scans of coronary arteries, which are rare and not always covered by insurance, to find heart disease, we seek to use AI to help screen abdominal CT scans that are done for many reasons," said study senior...
"In our current study, at week 4 after ischemia/reperfusion, we observed a significant 35.8 percent decrease in the infarct area in the hearts treated with the KO/OEhiPSC-cardiomyocyte spheroids," said Jianyi "Jay" Zhang, MD, PhD.
"In our current study, at week 4 after ischemia/reperfusion, we observed a significant 35.8 percent decrease in the infarct area in the hearts treated with the KO/OEhiPSC-cardiomyocyte spheroids," said Jianyi "Jay" Zhang, MD, PhD.
The study, published in the Journal of the American College of Cardiology (JACC), looked at detailed heart imaging data from 3,635 people who lived close to four major airports in England.
The study, published in the Journal of the American College of Cardiology (JACC), looked at detailed heart imaging data from 3,635 people who lived close to four major airports in England.
Women may be missing a diagnosis of a potentially deadly heart condition due to guidelines that don't account for natural differences in sex and body size, according to a new study led by UCL (University College London) researchers and funded...
Women may be missing a diagnosis of a potentially deadly heart condition due to guidelines that don't account for natural differences in sex and body size, according to a new study led by UCL (University College London) researchers and funded...
In a national study of over 40,000 people with Medicare and commercial insurance, 81.6% of patients did not have to pay for their initial cardiac rehabilitation session. The medically supervised program lasts up to 36 sessions.
In a national study of over 40,000 people with Medicare and commercial insurance, 81.6% of patients did not have to pay for their initial cardiac rehabilitation session. The medically supervised program lasts up to 36 sessions.
The authors report the mid-term outcomes following transcatheter edge-to-edge repair using the ValveClamp system from a multi-center database of patients with both atrial and ventricular secondary mitral regurgitation (MR_ and further...
The authors report the mid-term outcomes following transcatheter edge-to-edge repair using the ValveClamp system from a multi-center database of patients with both atrial and ventricular secondary mitral regurgitation (MR_ and further...
Boston Scientific News
Boston Scientific Corporation announced data supporting the use of the WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device during a late-breaking science session at AF Symposium 2025.
A prespecified...
Boston Scientific News
Boston Scientific Corporation announced data supporting the use of the WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device during a late-breaking science session at AF Symposium 2025.
A prespecified...
A 70-year-old man presented to the emergency department with chest pain for the past 5 days. His cardiovascular history was unremarkable, except for smoking. Upon arrival, the electrocardiogram demonstrated findings consistent with inferior...
A 70-year-old man presented to the emergency department with chest pain for the past 5 days. His cardiovascular history was unremarkable, except for smoking. Upon arrival, the electrocardiogram demonstrated findings consistent with inferior...